Log In
Print this Print this

PF-05285401, PF-5285401

  Manage Alerts
Collapse Summary General Information
Company Pfizer Inc.
DescriptionMultipotent adult progenitor cell
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic
Latest Stage of DevelopmentPhase II
Standard IndicationInflammatory bowel disease (IBD)
Indication DetailsTreat ulcerative colitis (UC)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today